|
WO2011091395A1
|
|
Antibodies for diagnosis and therapeutic treatment of prostate cancer
|
|
US2010286252A1
|
|
Human fg01 gene and its applications
|
|
NZ601733A
|
|
Antibody with binding specificity for Robo1 protein for inhibiting the infectivity of HIV
|
|
US2011152343A1
|
|
Protease inhibitors and broad-spectrum antiviral
|
|
US2010286248A1
|
|
Human fg01 gene and its applications
|
|
US2010035925A1
|
|
Compounds, pharmaceutical compositions an dmethods for inhibiting hiv infectivity
|
|
EP2203065A2
|
|
Methods of inhibiting viral infection
|
|
BRPI0818844A2
|
|
Methods of inhibiting viral infection.
|
|
MX2009005026A
|
|
Anti-tsg101 antibodies and their uses for treatment of viral infections.
|
|
AU2007352346A1
|
|
Random homozygous gene perturbation to enhance antibody production
|
|
WO2006004608A1
|
|
Compounds, pharmaceutical compositions and methods for inhibiting hiv infectivity
|
|
CA2500596A1
|
|
Anti-tsg101 antibodies and their uses for treatment of viral infections
|
|
AU2003268135A8
|
|
Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
|
|
AU2003265525A8
|
|
Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
|
|
WO03094841A2
|
|
Mammalian genes involed in rapamycin resistance and tumorgenesis: annexin xiii genes
|
|
WO03027260A2
|
|
Methods and compositions for generating homozygous mutations
|
|
AU2002337769A1
|
|
Methods and compositions for gene targeting by homologous recombination
|
|
US5922617A
|
|
Rapid screening assay methods and devices
|
